High mortality of COVID-19 associated mucormycosis in France: a nationwide retrospective study

  1. François Danion
  2. Valérie Letscher-Bru
  3. Juliette Guitard
  4. Karine Sitbon
  5. Sarah Dellière
  6. Adela Angoulvant
  7. Guillaume Desoubeaux
  8. Francoise Botterel
  9. Anne-Pauline Bellanger
  10. Gilles Gargala
  11. Fabrice Uhel
  12. Marie-Elisabeth Bougnoux
  13. Victor Gerber
  14. Justin Michel
  15. Marjorie Cornu
  16. Stéphane Bretagne
  17. Fanny Lanternier
  18. the COVID-Mucor study group
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus 95% in India), hematological malignancies (35% versus 1%), anatomical sites (53% lung versus >80% rhino-orbito-cerebral) and prognosis (>80% mortality versus <50%).

Related articles

Related articles are currently not available for this article.